Oliver Luxxe Assets LLC Astrazeneca PLC Transaction History

Oliver Luxxe Assets LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 17, 2018	SELL	$32.97 - $36.63 $3.66 Million - $4.06 Million	-110,859 Closed	0 $0
Q4 2017 Jan 16, 2018	SELL	$32.09 - $34.78 $181,404 - $196,611	-5,653 Reduced 4.85%	110,859 $3.85 Million
Q3 2017 Oct 23, 2017	BUY	$28.96 - $34.0 $3.37 Million - $3.96 Million	116,512	116,512 $3.95 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

Stay updated on Oliver Luxxe Assets LLC with notifications on news.